{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:10:06Z","timestamp":1782126606632,"version":"3.54.5"},"reference-count":82,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Critical genetic and hormonal switches characterize fetal sex development in humans. They are decisive for gonadal sex determination and subsequent differentiation of the genital and somatic sex phenotype. Only at the first glace these switches seem to behave like the dual 0 and 1 system in computer sciences and lead invariably to either typically male or female phenotypes. More recent data indicate that this model is insufficient. In addition, in case of distinct mutations, many of these switches may act variably, causing a functional continuum of alterations of gene functions and -dosages, enzymatic activities, sex hormone levels, and sex hormone sensitivity, giving rise to a broad clinical spectrum of biological differences of sex development (DSD) and potentially diversity of genital and somatic sex phenotypes. The gonadal anlage is initially a bipotential organ that can develop either into a testis or an ovary. <jats:italic>Sex-determining region Y (SRY)<\/jats:italic> is the most important upstream switch of gonadal sex determination inducing <jats:italic>SOX9<\/jats:italic> further downstream, leading to testicular Sertoli cell differentiation and the repression of ovarian pathways. If <jats:italic>SRY<\/jats:italic> is absent (virtually \u201cswitched off\u201d), e.\u200ag., in 46,XX females, <jats:italic>RSPO1, WNT4, FOXL2<\/jats:italic>, and other factors repress the male pathway and promote ovarian development. Testosterone and its more potent derivative, dihydrotestosterone (DHT) as well as AMH, are the most important upstream hormonal switches in phenotypic sex differentiation. Masculinization of the genitalia, i.\u200ae., external genital midline fusion forming the scrotum, growth of the genital tubercle, and Wolffian duct development, occurs in response to testosterone synthesized by steroidogenic cells in the testis. M\u00fcllerian ducts will not develop into a uterus and fallopian tubes in males due to Anti-M\u00fcllerian-Hormone (AMH) produced by the Sertoli cells. The functionality of these two hormone-dependent switches is ensured by their corresponding receptors, the intracellular androgen receptor (AR) and the transmembrane AMH type II receptor. The absence of high testosterone and high AMH is crucial for anatomically female genital development during fetal life. Recent technological advances, including single-cell and spatial transcriptomics, will likely shed more light on the nature of these molecular switches. <\/jats:p>","DOI":"10.1515\/medgen-2023-2036","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T11:11:07Z","timestamp":1692097867000},"page":"163-171","source":"Crossref","is-referenced-by-count":5,"title":["Classic genetic and hormonal switches during fetal sex development and beyond"],"prefix":"10.1515","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9308-3129","authenticated-orcid":false,"given":"Paul-Martin","family":"Holterhus","sequence":"first","affiliation":[{"name":"Christian-Albrechts University of Kiel (CAU) Pediatric Endocrinology and Diabetes, Department of Pediatrics I Kiel Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4411-6879","authenticated-orcid":false,"given":"Alexandra","family":"Kulle","sequence":"additional","affiliation":[{"name":"Christian-Albrechts University of Kiel (CAU) Pediatric Endocrinology and Diabetes, Department of Pediatrics I Kiel Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-4521","authenticated-orcid":false,"given":"Hauke","family":"Busch","sequence":"additional","affiliation":[{"name":"University of L\u00fcbeck Medical Systems Biology Group, L\u00fcbeck Institute of Experimental Dermatology (LIED) Ratzeburger Allee 160 L\u00fcbeck Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-4683","authenticated-orcid":false,"given":"Malte","family":"Spielmann","sequence":"additional","affiliation":[{"name":"University of L\u00fcbeck Institute of Human Genetics L\u00fcbeck Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"2024080713011958533_j_medgen-2023-2036_ref_001","doi-asserted-by":"crossref","unstructured":"[1]\tFrancke U, Holmes LB, Atkins L, Riccardi VM. Aniridia-Wilms\u2019 tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet. 1979;24:185\u201392. doi:10.1159\/000131375.","DOI":"10.1159\/000131375"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_002","doi-asserted-by":"crossref","unstructured":"[2]\tPelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, et al. Germline mutations in the Wilms\u2019 tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991;67:437\u201347. doi:10.1016\/0092-8674(91)90194-4.","DOI":"10.1016\/0092-8674(91)90194-4"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_003","doi-asserted-by":"crossref","unstructured":"[3]\tBarbaux S, Niaudet P, Gubler MC, Gr\u00fcnfeld JP, Jaubert F, Kuttenn F, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet. 1997;17:467\u201370. doi:10.1038\/ng1297-467.","DOI":"10.1038\/ng1297-467"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_004","doi-asserted-by":"crossref","unstructured":"[4]\tBiason-Lauber A, Konrad D, Meyer M, DeBeaufort C, Schoenle EJ. Ovaries and female phenotype in a girl with 46,XY karyotype and mutations in the CBX2 gene. Am J Hum Genet. 2009;84:658\u201363. doi:10.1016\/j.ajhg.2009.03.016.","DOI":"10.1016\/j.ajhg.2009.03.016"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_005","doi-asserted-by":"crossref","unstructured":"[5]\tAchermann JC, Ito M, Hindmarsh PC, Jameson JL. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet. 1999;22:125\u20136. doi:10.1038\/9629.","DOI":"10.1038\/9629"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_006","doi-asserted-by":"crossref","unstructured":"[6]\tHarley VR, Clarkson MJ, Argentaro A. The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 SRY-related high-mobility group (HMG) box 9. Endocr Rev. 2003;24:466\u201387. doi:10.1210\/er.2002-0025.","DOI":"10.1210\/er.2002-0025"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_007","doi-asserted-by":"crossref","unstructured":"[7]\tHiramatsu R, Matoba S, Kanai-Azuma M, Tsunekawa N, Katoh-Fukui Y, Kurohmaru M, et al. A critical time window of Sry action in gonadal sex determination in mice. Development. 2009;136:129\u201338. doi:10.1242\/dev.029587.","DOI":"10.1242\/dev.029587"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_008","doi-asserted-by":"crossref","unstructured":"[8]\tKoopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature. 1991;351:117\u201321. doi:10.1038\/351117a0.","DOI":"10.1038\/351117a0"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_009","doi-asserted-by":"crossref","unstructured":"[9]\tWang T, Liu JH, Yang J, Chen J, Ye ZQ. 46, XX male sex reversal syndrome: a case report and review of the genetic basis. Andrologia. 2009;41:59\u201362. doi:10.1111\/j.1439-0272.2008.00889.x.","DOI":"10.1111\/j.1439-0272.2008.00889.x"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_010","doi-asserted-by":"crossref","unstructured":"[10]\tHawkins JR. Mutational analysis of SRY in XY females. Hum Mutat. 1993;2:347\u201350. doi:10.1002\/humu.1380020504.","DOI":"10.1002\/humu.1380020504"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_011","doi-asserted-by":"crossref","unstructured":"[11]\tLarney C, Bailey TL, Koopman P. Switching on sex: transcriptional regulation of the testis-determining gene Sry. Development. 2014;141:2195\u2013205. doi:10.1242\/dev.107052.","DOI":"10.1242\/dev.107052"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_012","doi-asserted-by":"crossref","unstructured":"[12]\tHanley NA, Hagan DM, Clement-Jones M, Ball SG, Strachan T, Salas-Cort\u00e9s L, et al. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mech Dev. 2000;91:403\u20137. doi:10.1016\/s0925-4773(99)00307-x.","DOI":"10.1016\/S0925-4773(99)00307-X"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_013","doi-asserted-by":"crossref","unstructured":"[13]\tFoster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, Stevanovi\u0107 M, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature. 1994;372:525\u201330. doi:10.1038\/372525a0.","DOI":"10.1038\/372525a0"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_014","doi-asserted-by":"crossref","unstructured":"[14]\tWagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell. 1994;79:1111\u201320. doi:10.1016\/0092-8674(94)90041-8.","DOI":"10.1016\/0092-8674(94)90041-8"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_015","doi-asserted-by":"crossref","unstructured":"[15]\tHuang B, Wang S, Ning Y, Lamb AN, Bartley J. Autosomal XX sex reversal caused by duplication of SOX9. Am J Med Genet. 1999;87:349\u201353. doi:10.1002\/(sici)1096-8628(19991203)87:4<349::aid-ajmg13>3.0.co;2-n.","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_016","doi-asserted-by":"crossref","unstructured":"[16]\tCox JJ, Willatt L, Homfray T, Woods CG. A SOX9 duplication and familial 46,XX developmental testicular disorder. N Engl J Med. 2011;364:91\u20133. doi:10.1056\/NEJMc1010311.","DOI":"10.1056\/NEJMc1010311"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_017","doi-asserted-by":"crossref","unstructured":"[17]\tPark SY, Tong M, Jameson JL. Distinct roles for steroidogenic factor 1 and desert hedgehog pathways in fetal and adult Leydig cell development. Endocrinology. 2007;148:3704\u201310. doi:10.1210\/en.2006-1731.","DOI":"10.1210\/en.2006-1731"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_018","doi-asserted-by":"crossref","unstructured":"[18]\tUmehara F, Tate G, Itoh K, Yamaguchi N, Douchi T, Mitsuya T, Osame M. A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet. 2000;67:1302\u20135. doi:10.1016\/S0002-9297(07)62958-9.","DOI":"10.1086\/321210"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_019","doi-asserted-by":"crossref","unstructured":"[19]\tWerner R, Merz H, Birnbaum W, Marshall L, Schr\u00f6der T, Reiz B, et al. 46,XY Gonadal Dysgenesis due to a Homozygous Mutation in Desert Hedgehog (DHH) Identified by Exome Sequencing. J Clin Endocrinol Metab. 2015;100:E1022-9. doi:10.1210\/jc.2015-1314.","DOI":"10.1210\/jc.2015-1314"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_020","doi-asserted-by":"crossref","unstructured":"[20]\tFukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, Nordenskj\u00f6ld A, et al. CXorf6 is a causative gene for hypospadias. Nat Genet. 2006;38:1369\u201371. doi:10.1038\/ng1900.","DOI":"10.1038\/ng1900"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_021","doi-asserted-by":"crossref","unstructured":"[21]\tChassot AA, Gregoire EP, Magliano M, Lavery R, Chaboissier MC. Genetics of ovarian differentiation: Rspo1, a major player. Sex Dev. 2008;2:219\u201327. doi:10.1159\/000152038.","DOI":"10.1159\/000152038"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_022","doi-asserted-by":"crossref","unstructured":"[22]\tBiason-Lauber A, Konrad D, Navratil F, Schoenle EJ. A WNT4 mutation associated with M\u00fcllerian-duct regression and virilization in a 46,XX woman. N Engl J Med. 2004;351:792\u20138. doi:10.1056\/NEJMoa040533.","DOI":"10.1056\/NEJMoa040533"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_023","doi-asserted-by":"crossref","unstructured":"[23]\tVainio S, Heikkil\u00e4 M, Kispert A, Chin N, McMahon AP. Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999;397:405\u20139. doi:10.1038\/17068.","DOI":"10.1038\/17068"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_024","doi-asserted-by":"crossref","unstructured":"[24]\tUhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, Kress J, et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell. 2009;139:1130\u201342. doi:10.1016\/j.cell.2009.11.021.","DOI":"10.1016\/j.cell.2009.11.021"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_025","doi-asserted-by":"crossref","unstructured":"[25]\tMatson CK, Murphy MW, Sarver AL, Griswold MD, Bardwell VJ, Zarkower D. DMRT1 prevents female reprogramming in the postnatal mammalian testis. Nature. 2011;476:101\u20134. doi:10.1038\/nature10239.","DOI":"10.1038\/nature10239"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_026","doi-asserted-by":"crossref","unstructured":"[26]\tLindeman RE, Gearhart MD, Minkina A, Krentz AD, Bardwell VJ, Zarkower D. Sexual cell-fate reprogramming in the ovary by DMRT1. Curr Biol. 2015;25:764\u201371. doi:10.1016\/j.cub.2015.01.034.","DOI":"10.1016\/j.cub.2015.01.034"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_027","doi-asserted-by":"crossref","unstructured":"[27]\tMeinel JA, Yumiceba V, K\u00fcnstner A, Schultz K, Kruse N, Kaiser FJ, et al. Disruption of the topologically associated domain at Xp21.2 is related to 46,XY gonadal dysgenesis. J Med Genet. 2023;60:469\u201376. doi:10.1136\/jmg-2022-108635.","DOI":"10.1136\/jmg-2022-108635"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_028","doi-asserted-by":"crossref","unstructured":"[28]\tWilson JD, George FW, Griffin JE. The hormonal control of sexual development. Science. 1981;211:1278\u201384. doi:10.1126\/science.7010602.","DOI":"10.1126\/science.7010602"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_029","doi-asserted-by":"crossref","unstructured":"[29]\tLee MM, Donahoe PK. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev. 1993;14:152\u201364. doi:10.1210\/edrv-14-2-152.","DOI":"10.1210\/edrv-14-2-152"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_030","doi-asserted-by":"crossref","unstructured":"[30]\tJosso N, Lamarre I, Picard JY, Berta P, Davies N, Morichon N, et al. Anti-m\u00fcllerian hormone in early human development. Early Hum Dev. 1993;33:91\u20139. doi:10.1016\/0378-3782(93)90204-8.","DOI":"10.1016\/0378-3782(93)90204-8"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_031","unstructured":"[31]\tJosso N, Picard JY, Rey R, Di Clemente N. Testicular anti-M\u00fcllerian hormone: history, genetics, regulation and clinical applications. Pediatr Endocrinol Rev. 2006;3:347\u201358."},{"key":"2024080713011958533_j_medgen-2023-2036_ref_032","doi-asserted-by":"crossref","unstructured":"[32]\tRey R, Picard JY. Embryology and endocrinology of genital development. Baillieres Clin Endocrinol Metab. 1998;12:17\u201333. doi:10.1016\/s0950-351x(98)80427-8.","DOI":"10.1016\/S0950-351X(98)80427-8"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_033","doi-asserted-by":"crossref","unstructured":"[33]\tPicard J-Y, Cate RL, Racine C, Josso N. The Persistent M\u00fcllerian Duct Syndrome: An Update Based Upon a Personal Experience of 157 Cases. Sex Dev. 2017;11:109\u201325. doi:10.1159\/000475516.","DOI":"10.1159\/000475516"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_034","doi-asserted-by":"crossref","unstructured":"[34]\tJosso N, Rey RA, Picard J-Y. Anti-m\u00fcllerian hormone: a valuable addition to the toolbox of the pediatric endocrinologist. Int J Endocrinol. 2013;2013:674105. doi:10.1155\/2013\/674105.","DOI":"10.1155\/2013\/674105"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_035","doi-asserted-by":"crossref","unstructured":"[35]\tJohannsen TH, Andersson A-M, Ahmed SF, Rijke YB de, Greaves RF, Hartmann MF, et al. Peptide hormone analysis in diagnosis and treatment of Differences of Sex Development: joint position paper of EU COST Action \u2018DSDnet\u2019 and European Reference Network on Rare Endocrine Conditions. Eur J Endocrinol. 2020;182:P1-P15. doi:10.1530\/EJE-19-0831.","DOI":"10.1530\/EJE-19-0831"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_036","doi-asserted-by":"crossref","unstructured":"[36]\tHornig NC, Holterhus P-M. Molecular basis of androgen insensitivity syndromes. Mol Cell Endocrinol. 2021;523:111146. doi:10.1016\/j.mce.2020.111146.","DOI":"10.1016\/j.mce.2020.111146"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_037","doi-asserted-by":"crossref","unstructured":"[37]\tSiiteri PK, Wilson JD. Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab. 1974;38:113\u201325. doi:10.1210\/jcem-38-1-113.","DOI":"10.1210\/jcem-38-1-113"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_038","doi-asserted-by":"crossref","unstructured":"[38]\tGoto M, Piper Hanley K, Marcos J, Wood PJ, Wright S, Postle AD, et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest. 2006;116:953\u201360. doi:10.1172\/JCI25091.","DOI":"10.1172\/JCI25091"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_039","doi-asserted-by":"crossref","unstructured":"[39]\tHolterhus PM HO. Geschlechter, Intersex, DSD- woher, wohin? In: Heinz-J\u00fcrgen Vo\u00df, editor. Die deutschsprachige Sexwissenschaft, Bestandsaufnahme und Ausblick: Geschlechter, Intersex, DSD- woher, wohin?: Psychosozial-Verlag; 2020. p. 367\u2013391.","DOI":"10.30820\/9783837976977-367"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_040","doi-asserted-by":"crossref","unstructured":"[40]\tTaguchi O, Cunha GR, Robboy SJ. Expression of nuclear estrogen-binding sites within developing human fetal vagina and urogenital sinus. Am J Anat. 1986;177:473\u201380. doi:10.1002\/aja.1001770405.","DOI":"10.1002\/aja.1001770405"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_041","doi-asserted-by":"crossref","unstructured":"[41]\tGlatstein IZ, Yeh J. Ontogeny of the estrogen receptor in the human fetal uterus. J Clin Endocrinol Metab. 1995;80:958\u201364. doi:10.1210\/jcem.80.3.7883857.","DOI":"10.1210\/jcem.80.3.7883857"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_042","doi-asserted-by":"crossref","unstructured":"[42]\tClements JA, Reyes FI, Winter JS, Faiman C. Studies on human sexual development. III. Fetal pituitary and serum, and amniotic fluid concentrations of LH, CG, and FSH. J Clin Endocrinol Metab. 1976;42:9\u201319. doi:10.1210\/jcem-42-1-9.","DOI":"10.1210\/jcem-42-1-9"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_043","unstructured":"[43]\tWinter JS, Faiman C, Reyes FI. Sex steroid production by the human fetus: its role in morphogenesis and control by gonadotropins. Birth Defects Orig Artic Ser. 1977;13:41\u201358."},{"key":"2024080713011958533_j_medgen-2023-2036_ref_044","doi-asserted-by":"crossref","unstructured":"[44]\tDel Valle I, Buonocore F, Duncan AJ, Lin L, Barenco M, Parnaik R, et al. A genomic atlas of human adrenal and gonad development. Wellcome Open Res. 2017;2:25. doi:10.12688\/wellcomeopenres.11253.2.","DOI":"10.12688\/wellcomeopenres.11253.2"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_045","doi-asserted-by":"crossref","unstructured":"[45]\tAl-Sharkawi M, Calonga-Sol\u00eds V, Dressler FF, Busch H, Hiort O, Werner R. Persistence of foetal testicular features in patients with defective androgen signalling. Eur J Endocrinol 2023. doi:10.1093\/ejendo\/lvad007.","DOI":"10.1093\/ejendo\/lvad007"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_046","doi-asserted-by":"crossref","unstructured":"[46]\tO\u2019Shaughnessy PJ, Baker PJ, Heikkil\u00e4 M, Vainio S, McMahon AP. Localization of 17beta-hydroxysteroid dehydrogenase\/17-ketosteroid reductase isoform expression in the developing mouse testis--androstenedione is the major androgen secreted by fetal\/neonatal leydig cells. Endocrinology. 2000;141:2631\u20137. doi:10.1210\/endo.141.7.7545.","DOI":"10.1210\/en.141.7.2631"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_047","doi-asserted-by":"crossref","unstructured":"[47]\tKremer H, Kraaij R, Toledo SP, Post M, Fridman JB, Hayashida CY, et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet. 1995;9:160\u20134. doi:10.1038\/ng0295-160.","DOI":"10.1038\/ng0295-160"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_048","doi-asserted-by":"crossref","unstructured":"[48]\tLin D, Sugawara T, Strauss JF, Clark BJ, Stocco DM, Saenger P, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 1995;267:1828\u201331. doi:10.1126\/science.7892608.","DOI":"10.1126\/science.7892608"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_049","doi-asserted-by":"crossref","unstructured":"[49]\tHiort O, Holterhus P-M, Werner R, Marschke C, Hoppe U, Partsch C-J, et al. Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46,XY sex reversal, and severe adrenal failure. J Clin Endocrinol Metab. 2005;90:538\u201341. doi:10.1210\/jc.2004-1059.","DOI":"10.1210\/jc.2004-1059"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_050","doi-asserted-by":"crossref","unstructured":"[50]\tRh\u00e9aume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, et al. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nat Genet. 1992;1:239\u201345. doi:10.1038\/ng0792-239.","DOI":"10.1038\/ng0792-239"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_051","doi-asserted-by":"crossref","unstructured":"[51]\tKagimoto K, Waterman MR, Kagimoto M, Ferreira P, Simpson ER, Winter JS. Identification of a common molecular basis for combined 17 alpha-hydroxylase\/17,20-lyase deficiency in two Mennonite families. Hum Genet. 1989;82:285\u20136. doi:10.1007\/BF00291172.","DOI":"10.1007\/BF00291172"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_052","doi-asserted-by":"crossref","unstructured":"[52]\tGeissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, et al. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet. 1994;7:34\u20139. doi:10.1038\/ng0594-34.","DOI":"10.1038\/ng0594-34"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_053","doi-asserted-by":"crossref","unstructured":"[53]\tAndersson S, Berman DM, Jenkins EP, Russell DW. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature. 1991;354:159\u201361. doi:10.1038\/354159a0.","DOI":"10.1038\/354159a0"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_054","doi-asserted-by":"crossref","unstructured":"[54]\tWilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev. 1993;14:577\u201393. doi:10.1210\/edrv-14-5-577.","DOI":"10.1210\/edrv-14-5-577"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_055","doi-asserted-by":"crossref","unstructured":"[55]\tSwart AC, Schloms L, Storbeck K-H, Bloem LM, Du Toit T, Quanson JL, et al. 11\u03b2-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5\u03b1-reductase yielding 11\u03b2-hydroxy-5\u03b1-androstanedione. J Steroid Biochem Mol Biol. 2013;138:132\u201342. doi:10.1016\/j.jsbmb.2013.04.010.","DOI":"10.1016\/j.jsbmb.2013.04.010"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_056","doi-asserted-by":"crossref","unstructured":"[56]\tAuchus RJ. The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab. 2004;15:432\u20138. doi:10.1016\/j.tem.2004.09.004.","DOI":"10.1016\/S1043-2760(04)00214-0"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_057","doi-asserted-by":"crossref","unstructured":"[57]\tFl\u00fcck CE, Meyer-B\u00f6ni M, Pandey AV, Kempn\u00e1 P, Miller WL, Schoenle EJ, Biason-Lauber A. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am J Hum Genet. 2011;89:201\u201318. doi:10.1016\/j.ajhg.2011.06.009.","DOI":"10.1016\/j.ajhg.2011.06.009"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_058","doi-asserted-by":"crossref","unstructured":"[58]\tFukami M. 11-Oxyandrogens from the viewpoint of pediatric endocrinology. Clin Pediatr Endocrinol. 2022;31:110\u20135. doi:10.1297\/cpe.2022-0029.","DOI":"10.1297\/cpe.2022-0029"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_059","doi-asserted-by":"crossref","unstructured":"[59]\tWerner R, Holterhus P-M. Androgen action. Endocr Dev. 2014;27:28\u201340. doi:10.1159\/000363610.","DOI":"10.1159\/000363610"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_060","doi-asserted-by":"crossref","unstructured":"[60]\tLubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS. Sequence of the intron\/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci U S A. 1989;86:9534\u20138. doi:10.1073\/pnas.86.23.9534.","DOI":"10.1073\/pnas.86.23.9534"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_061","doi-asserted-by":"crossref","unstructured":"[61]\tSinnecker GH, Hiort O, Nitsche EM, Holterhus PM, Kruse K. Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group. Eur J Pediatr. 1997;156:7\u201314. doi:10.1007\/s004310050542.","DOI":"10.1007\/s004310050542"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_062","doi-asserted-by":"crossref","unstructured":"[62]\tDePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, et al. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 2002;3:RESEARCH0032. doi:10.1186\/gb-2002-3-7-research0032.","DOI":"10.1186\/gb-2002-3-7-research0032"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_063","doi-asserted-by":"crossref","unstructured":"[63]\tPetiot A, Perriton CL, Dickson C, Cohn MJ. Development of the mammalian urethra is controlled by Fgfr2-IIIb. Development. 2005;132:2441\u201350. doi:10.1242\/dev.01778.","DOI":"10.1242\/dev.01778"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_064","doi-asserted-by":"crossref","unstructured":"[64]\tMatsushita S, Suzuki K, Murashima A, Kajioka D, Acebedo AR, Miyagawa S, et al. Regulation of masculinization: androgen signalling for external genitalia development. Nat Rev Urol. 2018;15:358\u201368. doi:10.1038\/s41585-018-0008-y.","DOI":"10.1038\/s41585-018-0008-y"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_065","doi-asserted-by":"crossref","unstructured":"[65]\tOkumu LA, Braden TD, Vail K, Simon L, Goyal HO. Low androgen induced penile maldevelopment involves altered gene expression of biomarkers of smooth muscle differentiation and a key enzyme regulating cavernous smooth muscle cell tone. J Urol. 2014;192:267\u201373. doi:10.1016\/j.juro.2013.11.101.","DOI":"10.1016\/j.juro.2013.11.101"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_066","doi-asserted-by":"crossref","unstructured":"[66]\tAmato CM, Yao HH-C. Developmental and sexual dimorphic atlas of the prenatal mouse external genitalia at the single-cell level. Proc Natl Acad Sci U S A 2021. doi:10.1073\/pnas.2103856118.","DOI":"10.1073\/pnas.2103856118"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_067","doi-asserted-by":"crossref","unstructured":"[67]\tAppari M, Werner R, W\u00fcnsch L, Cario G, Demeter J, Hiort O, et al. Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. J Mol Med (Berl). 2009;87:623\u201332. doi:10.1007\/s00109-009-0462-3.","DOI":"10.1007\/s00109-009-0462-3"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_068","doi-asserted-by":"crossref","unstructured":"[68]\tHornig NC, Ukat M, Schweikert HU, Hiort O, Werner R, Drop SLS, et al. Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity. J Clin Endocrinol Metab. 2016;101:4468\u201377. doi:10.1210\/jc.2016-1990.","DOI":"10.1210\/jc.2016-1990"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_069","doi-asserted-by":"crossref","unstructured":"[69]\tHornig NC, Rodens P, D\u00f6rr H, Hubner NC, Kulle AE, Schweikert H-U, et al. Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II). J Clin Endocrinol Metab. 2018;103:4617\u201327. doi:10.1210\/jc.2018-00052.","DOI":"10.1210\/jc.2018-00052"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_070","doi-asserted-by":"crossref","unstructured":"[70]\tKnerr J, Werner R, Schwan C, Wang H, Gebhardt P, Gr\u00f6tsch H, et al. Formin-mediated nuclear actin at androgen receptors promotes transcription. Nature 2023. doi:10.1038\/s41586-023-05981-1.","DOI":"10.21203\/rs.3.rs-1664650\/v1"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_071","doi-asserted-by":"crossref","unstructured":"[71]\tTyson JJ, Chen KC, Novak B. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol. 2003;15:221\u201331. doi:10.1016\/S0955-0674(03)00017-6.","DOI":"10.1016\/S0955-0674(03)00017-6"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_072","doi-asserted-by":"crossref","unstructured":"[72]\tKim J, Kim T-G, Jung SH, Kim J-R, Park T, Heslop-Harrison P, Cho K-H. Evolutionary design principles of modules that control cellular differentiation: consequences for hysteresis and multistationarity. Bioinformatics. 2008;24:1516\u201322. doi:10.1093\/bioinformatics\/btn229.","DOI":"10.1093\/bioinformatics\/btn229"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_073","unstructured":"[73]\tWink M, editor. An introduction to molecular biotechnology: Fundamentals, methods and applications. Weinheim: Wiley-VCH; 2021."},{"key":"2024080713011958533_j_medgen-2023-2036_ref_074","unstructured":"[74]\tKlipp E, Liebermeister W, Wierling C, Kowald A. Systems biology: A textbook. Weinheim, M\u00fcnchen: Wiley-VCH; Ciando; 2016."},{"key":"2024080713011958533_j_medgen-2023-2036_ref_075","doi-asserted-by":"crossref","unstructured":"[75]\tSchwab JD, K\u00fchlwein SD, Ikonomi N, K\u00fchl M, Kestler HA. Concepts in Boolean network modeling: What do they all mean? Comput Struct Biotechnol J. 2020;18:571\u201382. doi:10.1016\/j.csbj.2020.03.001.","DOI":"10.1016\/j.csbj.2020.03.001"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_076","doi-asserted-by":"crossref","unstructured":"[76]\tR\u00edos O, Frias S, Rodr\u00edguez A, Kofman S, Merchant H, Torres L, Mendoza L. A Boolean network model of human gonadal sex determination. Theor Biol Med Model. 2015;12:26. doi:10.1186\/s12976-015-0023-0.","DOI":"10.1186\/s12976-015-0023-0"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_077","doi-asserted-by":"crossref","unstructured":"[77]\tCivelek M, Lusis AJ. Systems genetics approaches to understand complex traits. Nat Rev Genet. 2014;15:34\u201348. doi:10.1038\/nrg3575.","DOI":"10.1038\/nrg3575"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_078","doi-asserted-by":"crossref","unstructured":"[78]\tVandereyken K, Sifrim A, Thienpont B, Voet T. Methods and applications for single-cell and spatial multi-omics. Nat Rev Genet. 2023:1\u201322. doi:10.1038\/s41576-023-00580-2.","DOI":"10.1038\/s41576-023-00580-2"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_079","doi-asserted-by":"crossref","unstructured":"[79]\tSubramanian I, Verma S, Kumar S, Jere A, Anamika K. Multi-omics Data Integration, Interpretation, and Its Application. Bioinform Biol Insights. 2020;14:1177932219899051. doi:10.1177\/1177932219899051.","DOI":"10.1177\/1177932219899051"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_080","doi-asserted-by":"crossref","unstructured":"[80]\tGao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. doi:10.1126\/scisignal.2004088.","DOI":"10.1126\/scisignal.2004088"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_081","doi-asserted-by":"crossref","unstructured":"[81]\tNicora G, Vitali F, Dagliati A, Geifman N, Bellazzi R. Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools. Front Oncol. 2020;10:1030. doi:10.3389\/fonc.2020.01030.","DOI":"10.3389\/fonc.2020.01030"},{"key":"2024080713011958533_j_medgen-2023-2036_ref_082","doi-asserted-by":"crossref","unstructured":"[82]\tGarcia-Alonso L, Lorenzi V, Mazzeo CI, Alves-Lopes JP, Roberts K, Sancho-Serra C, et al. Single-cell roadmap of human gonadal development. Nature. 2022;607:540\u20137. doi:10.1038\/s41586-022-04918-4.","DOI":"10.1038\/s41586-022-04918-4"}],"container-title":["Medizinische Genetik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/medgen-2023-2036\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/medgen-2023-2036\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T13:03:22Z","timestamp":1723035802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/medgen-2023-2036\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,8,16]]},"published-print":{"date-parts":[[2023,8,8]]}},"alternative-id":["10.1515\/medgen-2023-2036"],"URL":"https:\/\/doi.org\/10.1515\/medgen-2023-2036","relation":{},"ISSN":["1863-5490","0936-5931"],"issn-type":[{"value":"1863-5490","type":"electronic"},{"value":"0936-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}